Hemp Stocks

560 Kommentare / 0 neu
03.01.2014 11:44
#1
Bild des Benutzers b00n
Offline
Kommentare: 5227
Hemp Stocks

 

 

Uruguay, Colorado Konsum legal

Div. US Bundesstaaten haben Medizinisches Marijane legalisiert...

weitere werden folgen..

nebst uruguay werden wohl noch andere Staaten in America sur folgen.

 

ganzer Sektor hat also enormes Wachstumpotential.

jetzt gilt es mal den spreu vom weizen zu trennen.

 

 

Ich fange mal an..

 


 

Aufklappen

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

vor 19 Stunden 59 Minuten
Bild des Benutzers logn
Offline
Kommentare: 330

Selector hat am 01.12.2016 - 20:42 folgendes geschrieben:

https://www.tweed.com/blogs/blog

Ja, man kann sie noch schön anwachsen lassen, sicher bis zur dieser Sitzung im Januar dann mal. Ev. werde ich dann nachfassen, ev. auch zu 11.80, falls nötig.

Auch von heute:

http://www.profitconfidential.com/stock/canopy-growth-430-million-deal-huge-pot-stocks/

 

@ Selector

Bis Ende Q1 2017 könnte Marapharm spannend werden.... Glaube das Unternehmen wurde bislang noch nicht erwähnt - deshalb melde ich mich auch wieder mal zu Worte.

Wünsche ein angenehmes Wochenende.

 

 

01.12.2016 20:42
Bild des Benutzers Selector
Offline
Kommentare: 568

https://www.tweed.com/blogs/blog

Ja, man kann sie noch schön anwachsen lassen, sicher bis zur dieser Sitzung im Januar dann mal. Ev. werde ich dann nachfassen, ev. auch zu 11.80, falls nötig.

Auch von heute: Biggrin

http://www.profitconfidential.com/stock/canopy-growth-430-million-deal-huge-pot-stocks/

 

01.12.2016 15:51
Bild des Benutzers Emil
Offline
Kommentare: 2865

Mega super, dass ich was habe, das auch im Winter wächst. Ich meine natürlich CGC. Yes 3

Emil

01.12.2016 09:36
Bild des Benutzers Selector
Offline
Kommentare: 568

CGC wächst und wächst... SmileDirol

Schöner Deal:

 

http://www.newswire.ca/news-releases/canopy-growth-enters-into-agreement-to-acquire-mettrum-603929436.html

Canopy Growth enters into agreement to acquire Mettrum

ignificant additional production capacity and brand diversification to Canopy Growth, Canada's leading cannabis company

  • Canopy Growth will add two national brands to its portfolio, increasing its production platform to 665,000 sq. ft., and furthering its position as a domestic and global leader.
  • Acquisition provides Canopy Growth with a full-spectrum product offering including expansion of medically-focused & lifestyle brands and the addition of a natural hemp brand.
  • Acquisition rounds out best in class management with significant industry experience.
  • Acquisition allows for sharing of best practices and production standards, with the potential to reduce costs and realize revenue synergies.
  • Mettrum shareholders to receive 0.7132 common shares (the "Exchange Ratio") of Canopy Growth for each common share of Mettrum.

SMITHS FALLS, ON and TORONTO, Dec. 1, 2016 /CNW/ - Canopy Growth Corporation (TSX: CGC) ("Canopy Growth" or the "Company") and Mettrum Health Corp. ("Mettrum") (TSXV: MT) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which Canopy Growth will acquire all of the issued and outstanding shares of Mettrum (the "Arrangement"), creating a world-leading diversified cannabis company with six licensed facilities, and a licensed production footprint of approximately 665,000 sq. ft., with significant acreage for expansion.

The total transaction is valued at approximately C$430 million and will be satisfied by the issuance of common shares in Canopy Growth. Under the terms of the Arrangement Agreement, Mettrum shareholders will be entitled to receive 0.7132 common shares of Canopy Growth for each common share of Mettrum, representing consideration of C$8.42 per Mettrum common share based on the closing price of Canopy Growth common shares on the Toronto Stock Exchange ("TSX") on November 30, 2016.  Upon completion of the Arrangement, existing Canopy Growth and Mettrum shareholders are expected to own approximately 77.7% and 22.3%, respectively, of the pro forma company.

Strategic Rationale

  • Dominant Market Position: Post-acquisition, Canopy Growth will continue to fortify its position as the largest medical marijuana company in Canada and as a global leader with total licensed production square footage of approximately 665,000 sq. ft., with significant acreage for additional expansion.
  • Expanded and Diversified Portfolio of Nationally Recognized Cannabis and Hemp Brands: The combined company will bring together Mettrum's simple, recognizable and proven Mettrum Spectrum brand, with the pure medically-focused brand of Bedrocan Canada and the approachable, lifestyle-focused brand of Tweed. On the hemp side of the business, the integration of Mettrum Originals with Canopy Growth's recently acquired hemp.ca platform will solidify Canopy Growth's position in the hemp market.
  • Cost and Revenue Synergies: The Company expects to realize improved supply chain management and back office efficiencies, cross-selling to customers given broader product offerings and combined research capabilities.
  • Industry-Leading Management Team: The combined company will have best in class management with significant and diverse industry experience.
  • Well-Capitalized for Further Global Growth: Post acquisition, Canopy Growth's cash balance of approximately $68 million positions the Company with one of the strongest balance sheets in the industry and leaves the Company well-funded for expansion and product development initiatives.
  • Enhanced Financial Scale and Presence: A widely-recognized and scalable platform to attract additional patients and to position the Company favourably within all distribution channels.

"From day one, Canopy Growth has viewed production capacity, brand diversity, and highly-skilled management as the foundational aspects of our business," said Bruce Linton, Chairman and CEO of Canopy Growth.  "Mettrum has established a line of cannabis products that work well in a medical context and will transition naturally into a natural and healthy lifestyle market. Their substantial production facilities will add to our growing production platform as we expand to meet the needs of patients, and their experienced personnel will help Canopy Growth drive our vision forward to the next level." Added Linton: "Both Canopy Growth and Mettrum have proven themselves with Canadian patients; and together we intend to make our industry-leading product and service offering even stronger, while developing our common hemp objectives."

"Canopy Growth and Mettrum have enjoyed a collaborative industry relationship working on a number of patient and industry advocacy efforts," said Michael Haines, CEO of Mettrum. "Combining our companies' complimentary market strengths, and management expertise, should result in a more dynamic company well-positioned for emerging recreational and international opportunities."

Arrangement Summary

The Arrangement Agreement provides that Mettrum shareholders will be entitled to receive 0.7132 common shares of Canopy Growth for each common share of Mettrum held, representing consideration of C$8.42 per Mettrum common share based on the closing price of Canopy Growth common shares on November 30, 2016. Upon closing of the acquisition, Mettrum will become a wholly-owned subsidiary of Canopy Growth.

Each of the executive officers and directors of Mettrum, who together hold approximately 15% of the outstanding common shares of Mettrum have entered into voting support agreements in favour of the Arrangement.

The Arrangement Agreement provides that Mettrum is subject to non-solicitation provisions and provides that the Special Committee of Mettrum may, under certain circumstances, terminate the Arrangement in favour of an unsolicited superior proposal, subject to a termination fee of C$10 million (the "Termination Fee") to Canopy Growth and subject to a right to match the superior proposal. The Arrangement Agreement includes other customary termination provisions where a Termination Fee is payable to Canopy Growth or Mettrum under certain circumstances.

The acquisition will be carried out by way of plan of arrangement under the Business Corporations Act (Ontario) and will require the approval of at least 66 2/3% of the votes cast by Mettrum shareholders at a special meeting expected to take place in January 2017.

Under applicable TSX rules, the transaction requires the approval of Canopy Growth shareholders by a majority vote, as the number of Canopy Growth common shares to be issued exceeds 25% of the total number of outstanding Canopy Growth common shares, with such approval expected to take place at a special meeting in January 2017. Senior officers and directors of Canopy Growth have also entered into voting support agreements pursuant to which they will vote their common shares in favour of the Arrangement. 

Closing remains subject to approval of the shareholders of both Canopy Growth and Mettrum, court approval, the approval of the TSX, applicable regulatory approvals and the satisfaction of certain other closing conditions customary in transactions of this nature.

Additional details of the Arrangement will be provided to Mettrum and Canopy Growth shareholders in respective information circulars to be mailed in December 2016. It is expected that shareholder meetings and closing of the Arrangement will occur in January 2017.

Board Recommendations

The Board of Directors of both Canopy Growth and Mettrum, have unanimously approved the transaction and recommend that shareholders vote in favour of the transaction. The Board of Directors of Mettrum has acted on the unanimous recommendation of the Special Committee comprised solely of independent directors. Dundee Securities Ltd. provided a fairness opinion to the Board of Directors of Canopy Growth, stating that in its opinion, and based upon and subject to the assumptions, limitations, and qualifications set forth therein, the Exchange Ratio pursuant to the Arrangement is fair, from a financial point of view, to the Canopy Growth shareholders. Cormark Securities Inc. has provided a fairness opinion to the Special Committee of the Board of Directors of Mettrum, stating that in its opinion, and based upon and subject to the assumptions, limitations, and qualifications set forth therein, the Exchange Ratio pursuant to the Arrangement is fair, from a financial point of view, to the Mettrum shareholders.  In addition, Echelon Wealth Partners Inc. provided a fairness opinion to the Special Committee of the Board of Directors of Mettrum, stating that the Arrangement is fair, from a financial point of view, to the Mettrum shareholders, subject to certain assumptions, limitations, and qualifications.

Integrated Quality Assurance Approach

The Company is confident that Mettrum's response to the events that led to the recall will result in operational practices that will advance the quality and standards of the production of cannabis at Mettrum's facilities.

Mettrum will continue to lead site activities with Health Canada as it fulfills its obligations for products affected by the previously announced Type III recall.

Canopy Growth has established a strong multi-site track record of regulatory compliance across diversified production sites, making it uniquely capable of implementing best practices and moving forward to the highest production standards under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") issued pursuant to the Controlled Drugs and Substances Act (Canada).

Financial and Legal Advisors

Dundee Securities Ltd. is acting as financial advisor to Canopy Growth with LaBarge Weinstein LLP acting as legal advisor to the Company.

Cormark Securities Inc. is acting as financial advisor to Mettrum, Goodmans LLP is acting as legal counsel to Mettrum and Aird & Berlis LLP is acting as legal counsel to the Special Committee of Mettrum.

Conference Call Information

Canopy Growth and Mettrum will host a joint conference call to discuss the transaction on December 1, 2016 at 8:30 a.m. (Eastern Daylight Time). A copy of the presentation can be found on Canopy's Growth's website at www.canopygrowth.com

Calling Information:
Toll Free Dial-In Number: 1-888-231-8191
International Dial-In Number (647) 427-7450
Conference ID: 30771775

Replay Information:
A replay of the call will be accessible by telephone until 11:59 PM ET on January 1, 2017.
Toll Free Dial-in Number: 1-855-859-2056
Replay Password: 30771775

A live audio webcast will be available here.

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms.  Through its wholly‑owned subsidiaries, Tweed, Tweed Farms, and Bedrocan Canada, Canopy Growth operates three state-of-the-art production facilities with over half a million square feet of indoor and greenhouse production capacity. Canopy Growth has established partnerships with leading sector names in Canada and abroad. For more information visit www.canopygrowth.com.

About Mettrum Health Corp.
Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly-owned subsidiary of Mettrum Health Corp., is a Toronto-based company and a licensed producer of medical cannabis under the ACMPR. Mettrum received its first license from Health Canada on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at the Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada on December 17, 2015 for Mettrum Ltd. at its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the company's three licenses, Mettrum Health Corp. is a leading producer and vendor of medical cannabis under the ACMPR system. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals™, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada).......

 

29.11.2016 15:38
Bild des Benutzers shanik82
Offline
Kommentare: 8
LDS Patent Filing for Advanced CannaStrips Formulations
29.11.2016 15:25
Bild des Benutzers petra129
Offline
Kommentare: 33

Speculative stock may be best bargain stock of 2016

image: https://www.adviceforinvestors.com/wp-content/uploads/userphoto/210.png

Investor’s Digest columnist Edward Gardiner may be no fan of the new Trudeau Liberal government, but he names one stock that may be the bargain of a generation if the government follows through with its promise to legalize marijuana.

Justin Trudeau’s first year hasn’t been too surprising. Trudeau the Younger has been in power for about a year now, and so far, other than spending a lot of money, he hasn’t caused too much damage.

That’s probably because he hasn’t made good on his more serious campaign promises. But he has laid the groundwork for some of them, so trouble is on the way.

He kept his promise to Statistics Canada about the long-form census questionnaire and now the number crunchers think they should run the country. Personally, I think many Canadians will ‘punish’ Stats Can by falsifying their answers going forward. After all, your answers are confidential, so you can’t be identified. In the meantime, Trudeau has to explain to the bureaucrats that they can’t have everything their own way.

He also kept the ‘internationalists’ happy by announcing that Canada is ‘back’ at the United Nations. Basically, all he did was suck up to a bunch of Third-World dictators and promise them lots of money. With any luck, he won’t ever have to make good on that promise.

On another note, he laid the groundwork for altering our electoral system. Whatever changes are forced on us, they will likely mean more power for party leaders and insiders and less for the ordinary citizen. I’m not sure what impact, if any, this will have on the markets.

Highly speculative play may be best bargain stock for 2016

His most interesting promise is the one to legalize marijuana. This is the one that probably won him the election by buying the votes of many millennials—a group that has had a poor turnout in recent elections, but managed a much better performance this time around.

I am reliably informed (by members of that generation) that many millennials voted for Mr. Trudeau solely because of his promise to legalize marijuana, despite being warned that the Liberal version will likely include a government monopoly and taxes that will make alcohol and tobacco look cheap.

If you want to take advantage of this opportunity, and have a tolerance for speculative stocks, you might consider Canopy Growth Corp. (TSX—CGC). It has no earnings yet, so I won’t buy it myself, but as a highly speculative stock it may be all right. And in 20 or 30 years, it, or others like it, should be highly profitable. The millennials are going to need those profits to pay for Trudeau’s largesse.

Read more at http://www.stockhouse.com/companies/bullboard/v.cgc/capital-gold-corpora...

 

....dass ich diese Aktie "verschenkt" habe ärgert mich schon....sehr! Fool

 

28.11.2016 13:40
Bild des Benutzers Emil
Offline
Kommentare: 2865

Supermegacool!

 

Nun habe ich auchnoch was erfreuliches gefunden heute zu CGC:  I-m so happy

 

SMITHS FALLS, ON, Nov. 28, 2016 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: CGC) today announced that it has entered into an agreement to acquire MedCann GmbH Pharma and Nutraceuticals (MedCann), a German-based pharmaceutical distributor who has successfully placed Tweed-branded cannabis strains in German pharmacies.

MedCann has proven its ability to navigate the complex regulatory environment for cannabis importation and distribution in Germany. With a highly experienced leadership team, led by Dr. Pierre Debs, it has established itself as a leading cannabis importer and distributor within Germany where the cannabis industry still relies solely on imported products.

"Germany has begun a process of enabling medical access to cannabis and through a policy that recognized Canopy as the first legal supply source from North America," said Bruce Linton, Chairman and CEO of Canopy Growth Corporation. "This acquisition establishes a distinct and purely medicinal corporate entity that helps us today but also positions us for domestic medicinal production inside Germany if the regulatory environment shifts."

The various production sites within Canopy have developed a track record of producing consistent strains that yield reliable cannabinoid profiles harvest over harvest, a federal requirement for cannabis exports entering Germany. At this time, Tweed is capable of producing numerous stabilized strains and will position MedCann well in this market. Bedrocan Canada products will not be provided to the German market due to license restrictions.

"Germans need access to high-quality cannabis and Tweed's products are proving to be up to the very strict standards set by the federal government," said Dr. P. Debs, founder of Medcann. "Working together as one team will allow Canopy Growth through Tweed, Tweed Farms, and future production sites to supply the unmet demand that has been building over the past decade."

Germany permitted patient access to medical cannabis in 2005. No domestic production currently exists with cannabis imports currently from Canada and Holland.

The acquisition is structured against certain licensing milestones that will move the Company towards domestic production opportunities. 674,631 common shares in the Company will be issued to MedCann upon the closing of the transaction. A further 367,981 commons shares in the Company will be issued on the 18-month anniversary of obtaining an Import and Distribution License from the German Health Minister. A further 122,660 common shares in the Company will be issued to MedCann principal upon achieving certain other milestones within two years of closing the transaction.

This incentivized structure, combined with Canopy Growth's experience establishing and expanding upon licensing form the foundation of a strong early market position in Europe's largest economy.

The acquisition is subject to the approval of the Toronto Stock Exchange.

Here's to Future Growth.

About Canopy Growth Corporation
Canopy Growth is publicly traded on the TSX and a leading diversified producer of medical cannabis through its wholly owned subsidiaries Tweed, Bedrocan Canada, and Tweed Farms. The Company operates a collection of diverse brands and curated strain variety, supported by over half a million square feet of indoor and greenhouse production capacity.

About MedCann GmbH Pharma and Nutraceuticals
MedCann GmbH was founded in June 2015 by Dr. Pierre Debs and Rainer Hofmann. MedCann GmbH is an importer, manufacturer and distributor of medical cannabis products and is federally licensed by the German Heath Ministry. Dr. Debs is a stem cell biologist with over 25 years research experience at world class research universities in the US and Europe. Rainer Hofmann is a successful businessman having established and directed a variety of businesses in the Heidelberg area for over 20 years. MedCann GmbH operates under strict GMP and GDP guidelines for all aspects of sourcing, transporting and releasing medical cannabis products.

Forward-Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, Tweed Inc., Tweed Farms Inc. or Bedrocan Canada Inc. to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation. Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

SOURCE Canopy Growth Corporation
 

For further information: Media: Jordan Sinclair, Jordan@tweed.com, 855-558-9333 ex 309; Investors: Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Director: Bruce Linton, CEO, tmx@tweed.com

RELATED LINKS
http://canopygrowth.com/

Release contains wide tables.
View fullscreen.Organization Profile

Canopy Growth Corporation

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start tRelease contains wide tables.
View fullscreen.oday.

CNW Membership

 

Emil

24.11.2016 20:40
Bild des Benutzers petra129
Offline
Kommentare: 33

Bruce Campbell 2posted November 24, 2016 01:53 pm  by  retiredcf Interesting final comment. GLTA The recent roll Canadian marijuana stocks have enjoyed seems to have gone up in smoke SmallCapPower | November 24, 2016: Marijuana investors in Canada have...read more ....Despite the recent stomach-churning ups and downs, Bruce Campbell contends that legal marijuana will be a “huge” growth industry for the next 10 years, both on the medical and recreational sides of the market. Longer term, the estimates are this sector could be $9-$11 billion in Canada: $3 billion of that from medical and $6-$7 billion from recreational. That will, of course, take years to build and develop, he said. And, to put that into perspective, the illegal marijuana black market in Canada is estimated at $10 billion, bigger than either wine or spirits.

In fact, Mr. Campbell is so positive on the Canadian marijuana space that his firm is in the process of launching a Marijuana sector fund.

Read more at http://www.stockhouse.com/companies/bullboard#MCLirRiTCSUJyIkK.99

.

...also alles in allem Yes 3

 

24.11.2016 09:30
Bild des Benutzers Selector
Offline
Kommentare: 568

Info für die Fans von CGC damit ihr was Neues zu lesen habt: SmileDirol

 

 Canopy Growth Corporation (Canopy Growth) (TSX: CGC) is pleased to provide the following update to its June 28, 2016 release on both the joint venture announcement with Entourage Phytolab (Entourage)  and the formation of Bedrocan Brasil (Bedrocan Brasil), both companies partly owned by Canopy Growth Corporation. 

First Export to South America

Canopy Growth's wholly-owned subsidiary Bedrocan Canada Inc. (Bedrocan Canada), has successfully exported 10 kg of dried cannabis to Brazil for research purposes. Securing a supply of standardized research grade cannabis is a major milestone in the Entourage clinical development plan and marks the first time to the Company's knowledge that medicinal cannabis from a Canadian Licensed Producer has been exported to South America.

Entourage will now begin clinical study drug preparation and stable pharmaceutical formulations needed for the development of a whole plant drug candidate targeting epilepsy and pain management for registration before the Brazilian health authority ANVISA anticipated in 2018.

"Brazil is an exciting international market for us," said Bruce Linton, Chairman and CEO of Canopy Growth. "Research will form the basis of a broader medicinal cannabis regime in the country and we are proud to be driving this innovation forward."

Initial Funding Secured

Canopy Growth, Entourage and Bedrocan Brasil have completed an initial funding round of $3 million USD in exchange for common shares in Entourage and Bedrocan Brasil. These funds will be used both for the continuing development of Bedrocan Brasil and the launch of the Entourage clinical research plan.

"I am extremely pleased by the early and steady progress in Brazil for both Bedrocan Brasil and Entourage," said Caio Abreu, CEO of Entourage and Bedrocan Brasil. Since our launch only 4 months ago, we are fully on track with our goals of ensuring we can deliver Brazilian patients with world class cannabis-based medicines made and registered in Brazil."

In addition, Entourage can now announce that Antonio Droghetti Neto has joined its Board of Directors. Mr. Droghetti is an economist and business administrator with expertise and broad experience in structuring start-up stage companies. He was the Vice President of Grupo Silvio Santos, CEO of Inframérica, concessionaire of the airport of Brasilia, and CEO of Lifemed, a company that develops products for hospitals and the health sector.

http://www.newswire.ca/news-releases/bedrocan-canada-completes-export-of-dried-cannabis-to-brazil-602757176.html

 

23.11.2016 14:44
Bild des Benutzers petra129
Offline
Kommentare: 33

Another Articleposted November 23, 2016 05:37 am  by  madmax240kph Profit taking brings high-flying Canadian marijuana stocks back to earth Republish Reprint MidasLetter | November 21, 2016 3:07 PM ET More from MidasLetter . High-flying marijuana stocks are on the...read more

22.11.2016 16:57
Bild des Benutzers shanik82
Offline
Kommentare: 8
CannaStrips

Lifestyle Delivery Systems Inc. announces Memorandum of Understanding for distribution of CannaStrips to Hundreds of Dispensaries in California

 

http://www.prnewswire.com/news-releases/lifestyle-delivery-systems-inc-announces-memorandum-of-understanding-for-distribution-of-cannastrips-to-hundreds-of-dispensaries-in-california-300367138.html

22.11.2016 16:39
Bild des Benutzers Selector
Offline
Kommentare: 568

Sehe grad bei einem Blick auf CGC dass sich wohl Kaufkurse anbieten.  Dirol

https://www.tweed.com/blogs/blog

Smile

 

22.11.2016 16:37
Bild des Benutzers petra129
Offline
Kommentare: 33
ein Blutbad.....

RE:NP article causing all the commotionposted November 22, 2016 10:25 am  by  Wambou  NP says Aphria, others hear vet med pot bill soaring   2016-11-22 08:49 ET - In the News See In the News (C-APH) Aphria Inc The National Post reports in its Tuesday, Nov. 22..

2016-11-22 08:49 ET - In the News

See In the News (C-APH) Aphria Inc

The National Post reports in its Tuesday, Nov. 22, edition that Veterans Affairs Canada is set to "reduce substantially" the amount of medical marijuana for which retired soldiers can seek reimbursement. The Post's John Ivison writes that the program under which veterans could access marijuana for medical purposes was introduced in 2008-2009 and by the end of the year there were just five recipients being reimbursed $19,000. An unnamed source says there are currently 3,300 users -- double the number from official statistics released in March -- and the department has projected the program will cost $90-million in the current fiscal year, if trends continue. To put that in context, the government spends about $247-million a year on all health treatments for veterans. Veterans Affairs Minister Kent Hehr said in March he would review the issue and he is expected to announce a dramatic reduction in the amount the department will reimburse from the current 10 grams a day. It is understood veterans will still be able to access whatever amount of marijuana is authorized by their doctors, but the government will not reimburse at current levels, unless there are exceptional circumstances.

© 2016 Canjex Publishing Ltd. All rights reserved

 

 

21.11.2016 17:52
Bild des Benutzers petra129
Offline
Kommentare: 33

@shanik82 - wenn möglich bleibe ich an den original Plätzen und zur Zeit gibt es ja unendlich viele Hemp Stocks. Danke Dir. Smile

21.11.2016 17:12
Bild des Benutzers Emil
Offline
Kommentare: 2865

Besten Dank, ich habe zugegriffen vor einigen Minuten.

Emil

21.11.2016 12:19
Bild des Benutzers shanik82
Offline
Kommentare: 8
This Chart is Bad News for Canopy Growth
21.11.2016 12:16
Bild des Benutzers shanik82
Offline
Kommentare: 8
LDS

petra129 hat am 18.11.2016 - 17:33 folgendes geschrieben:

RE:RE:No more stop orders on MJ stocks

posted November 18, 2016 08:38 am  by  jmthibs

  "In light of recent volatility in Canadian marijuana stocks, please be reminded that Stop orders are not accepted on the Canadian Securities Exchange (CSE). Stop orders include Stop Market, Stop Limit, Trailing Stop Market, and Trailing Stop Limit orders. If you place a Stop order for a CSE-listed security, the order will be rejected. If you require assistance, please contact an Investment Representative at 1-800-465-5463. Thank you for choosing TD Direct Investing." showing 3.90/906 - 3.90/1792 at 9:38 ATL
Read more at http://www.stockhouse.com/companies/bullboard#QvW1ujwVRtb1TzBL.99 ...hat wohl einen echten shit-storm gegeben bei diesen "Regulatoren"....ob das nur für die CSE gilt? @shanik82 - an die LDS komme ich über meinen Provider nicht direkt ran, für Vancouver und Toronto habe ich immer real time Kurse.

@petra129 - ich komme über meinen Provider auch nicht direkt an LDS. Daher bin ich via Frankfurt investiert (LD6). Denke LDS ist eine sehr innovative, interessante Firma mit Potenzial.

20.11.2016 18:57
Bild des Benutzers petra129
Offline
Kommentare: 33

Marijuana stocks - BNN Comparing the 5 BestJacob Capital Management says the advent of a large recreational market should see these stocks higher in a year's time but during the next six months, there will probably be some alarming dips and steep rises....

Aphria the safest, Aurora the most aggressive building clients.

http://www.bnn.ca/commodities/video/marijuana-stocks-volatility-baked-in...

....man sollte genau hinhören, er redet sehr schnell aber ich meine sehr gut.
 

 

18.11.2016 21:21
Bild des Benutzers Emil
Offline
Kommentare: 2865

Ich glaube, wenn ich sage, dass ich jetzt noch etwas CGC kaufe, geht der Kurs noch etwas runter. Wäre super!

 

Emil

18.11.2016 18:23
Bild des Benutzers petra129
Offline
Kommentare: 33

2brix hat am 18.11.2016 - 18:08 folgendes geschrieben:

petra129 hat am 18.11.2016 - 13:50 folgendes geschrieben:

....also mit einem Bein sollte man schon drinstehen - besonders wenn weiterhin so gute Nachrichten für diese Branche

kommen

...

sehe ich schon auch so, die Frage ist halt mehr wo?

Teils sind halt schon sehr hoch gelaufen, werde daher wohl eher mal abwarten.

....and here we go again - schon wieder wie auf Kommando, das ist echt Schei**e.

Wer jetzt was übrig hat.....http://de.advfn.com/borse/TSX/CGC/kurs

muss jeder selber wissen - ist eben heiss gelaufen.

18.11.2016 18:08
Bild des Benutzers 2brix
Offline
Kommentare: 2175

petra129 hat am 18.11.2016 - 13:50 folgendes geschrieben:

....also mit einem Bein sollte man schon drinstehen - besonders wenn weiterhin so gute Nachrichten für diese Branche

kommen

...

sehe ich schon auch so, die Frage ist halt mehr wo?

Teils sind halt schon sehr hoch gelaufen, werde daher wohl eher mal abwarten.

18.11.2016 17:33
Bild des Benutzers petra129
Offline
Kommentare: 33

RE:RE:No more stop orders on MJ stocks

posted November 18, 2016 08:38 am  by  jmthibs

  "In light of recent volatility in Canadian marijuana stocks, please be reminded that Stop orders are not accepted on the Canadian Securities Exchange (CSE). Stop orders include Stop Market, Stop Limit, Trailing Stop Market, and Trailing Stop Limit orders. If you place a Stop order for a CSE-listed security, the order will be rejected. If you require assistance, please contact an Investment Representative at 1-800-465-5463. Thank you for choosing TD Direct Investing." showing 3.90/906 - 3.90/1792 at 9:38 ATL
Read more at http://www.stockhouse.com/companies/bullboard#QvW1ujwVRtb1TzBL.99 ...hat wohl einen echten shit-storm gegeben bei diesen "Regulatoren"....ob das nur für die CSE gilt? @shanik82 - an die LDS komme ich über meinen Provider nicht direkt ran, für Vancouver und Toronto habe ich immer real time Kurse.

18.11.2016 14:09
Bild des Benutzers shanik82
Offline
Kommentare: 8
CannaStrips für ganz Kalifornien: Perfektes Timing
18.11.2016 13:50
Bild des Benutzers petra129
Offline
Kommentare: 33

....also mit einem Bein sollte man schon drinstehen - besonders wenn weiterhin so gute Nachrichten für diese Branche

kommen

Australia Has Just Legalized Medical Marijuana Across the Entire Continent

Australia has made become the first entire continent to legalise marijuana, after their Parliament took a vote on Wednesday....

 

http://www.organicandhealthy.org/2016/11/medical-marijuana-is-legalized-...

....vielleicht überdenken  unsere Gesetzeshüter erst einmal bevor sie einen Hanfanbauer hinter Gitter stecken, es ist ja schon peinlich.

18.11.2016 12:35
Bild des Benutzers Selector
Offline
Kommentare: 568

Die vorletzten Zahlen waren auch nicht so überzeugend, drum ging ich damals kurz raus danach. Es kam zu einem leichten Kursrückgang, den ich nutzte. Ich bin aber seit Montag, kurz vor Schluss weg. Habe also die Super-Rally-Achterbahnfahrt nicht mitgemacht. Kein Grund traurig zu sein. Reich geworden bin ich auch nicht damit. Interessant finde ich das Weitere trotzdem. Ev. kaufe hier nochmals was, muss sehen was der Kurs macht.

18.11.2016 11:27
Bild des Benutzers 2brix
Offline
Kommentare: 2175

petra129 hat am 18.11.2016 - 09:23 folgendes geschrieben:

@Selector (und natürlich an alle Interessierten....)

....mir kommen eh die Tränen wenn ich in meinen Unterlagen blättere - bei Canopy raus mit Can$ 4.07 und dann überall etwas rumgehüpft  jetzt sind sie mir einfach optisch zu teuer. APH und OGI sind auch nicht schlecht, aber eben kein Vergleich.

 OrganiGram Facility Organic Super Producer

posted November 18, 2016 12:03 am  by  TripleBagg3r
 

 

aus dem OGI-Forum mit kurzem Video.

 

 

@petra, kannst dich trösten. Zuerst wurde mein Kauf glaubs ~2$ nur Teilausgeführt. Mit dieser Kleinmenge bin ich dann auch bei ~5-6 raus und dachte ich könnte dann noch günstig wieder aufsteigen. Danach habe ich der ganzen Sache nicht mehr so getraut. Die vorletzten Zahlen haben mich zudem auch nicht überzeugt.

 

Aktuell habe ich keine Marijuana-Positionen. Weiss auch nicht wirklich, wo sich noch ein Einstieg lohnt.

18.11.2016 09:23
Bild des Benutzers petra129
Offline
Kommentare: 33

@Selector (und natürlich an alle Interessierten....)

....mir kommen eh die Tränen wenn ich in meinen Unterlagen blättere - bei Canopy raus mit Can$ 4.07 Cray 2 und dann überall etwas rumgehüpft  Fool jetzt sind sie mir einfach optisch zu teuer. APH und OGI sind auch nicht schlecht, aber eben kein Vergleich.

 OrganiGram Facility Organic Super Producer posted November 18, 2016 12:03 am  by  TripleBagg3r 

 

aus dem OGI-Forum mit kurzem Video.

 

 

17.11.2016 18:09
Bild des Benutzers Selector
Offline
Kommentare: 568

@Petra

Zu CGC: Zur Beruhigung, heute schaut hier alles wieder ganz normal aus. Es scheint, dass es gestern zu einer Art ÜBERREAKTION gekommen ist, da sehr viele in dem Sektor noch aufgesprungen sind und auch mal kurz getradet haben. Gewinnmitnahmen sind natürlich auch hier gelaufen.

Hier noch etwas Infos:

https://www.tweed.com/blogs/blog

Kann via Mail bestellt werden.

Und

von Dienstag, Anfang diese Woche:

http://www.cbc.ca/news/business/canopy-growth-marijuana-1.3851351?cmp=rss

 

 

 

16.11.2016 22:11
Bild des Benutzers petra129
Offline
Kommentare: 33

@Selector

...so man Reserve hat ist alles halb so schlimm - aber das Ganze ist schon sehr spekulativ. Und die Info unten scheint mir etwas dürftig - schliesslich löste --> controlling short term, unexplained price volatility  nicht nur eben das aus sondern auch ein ziemliches Chaos. Und nicht alle Aktien wurden gleich behandelt - so scheint es mir zumindest. Na ja wir werden's überleben.

HaultAs requested here is the information we discussed concerning Single Stock Circuit Breakers: SSCB’s are intended to operate as part of a multi-tiered approach to controlling short term, unexplained price volatility. Each set of controls will ultimately play an important role in the overall framework designed to mitigate the risks associated with “unexplained short term price movement” and promote “fair and orderly” markets.  For more robust information on Single Stock Circuit Breakers, please refer to the following: UMIR Notice Guidance Note 12-0040-Guidance Respecting the Implementation of Single-Stock Circuit Breakers <http://www.iiroc.ca/Documents/2012/7cf90cce-57ae-4760-822a-46b1525e2051_... , and Guidance Respecting the Expansion of Single-Stock Circuit Breakers <http://docs.iiroc.ca/DisplayDocument.aspx?DocumentID=08873044821541289D8... Update Respecting the Expansion of Single-Stock Circuit Breakers <http://www.iiroc.ca/Documents/2015/d59c477b-4fcd-419c-83fe-2f43582867fa_... Sincerely,  Debra HaggartySr. Complaints & Inquiries SpecialistInvestment Industry Regulatory Organization of Canada121 King St. W., Ste. 2000, Toronto, Ontario M5H 3T91-877-442-4322Inquiries@iiroc.ca
Read more at http://www.stockhouse.com/companies/bullboard#PuZs1iZZoKGueBt5.99

 

16.11.2016 21:49
Bild des Benutzers Emil
Offline
Kommentare: 2865

Wink

Glaube die TSX hat auch ein Problem heute, nun geben sie bei CGC den Eröffnungskurs von heute mit 9.75 an. Gesehen habe ich den aber vor einer guten Stunde noch um  über 16.- rum. Sei ja auch noch Verfall diese Woche...reicht vermutlich bis Kanada .

Emil

Seiten